<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet" id="list7-0020731420946590">
 <list-item>
  <p>The vaccine and Tenofovir treatment are effective.
   <sup>
    <xref rid="bibr40-0020731420946590" ref-type="bibr">40</xref>
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>Hepatitis B (HBV) is highly contagious. Its R0 is 5 when there is no intervention.</p>
 </list-item>
 <list-item>
  <p>In 2015, 257 million were infected worldwide, of which 27 million were diagnosed and 4.5 million treated.</p>
 </list-item>
 <list-item>
  <p>4,2/°° of acute viral hepatitis cases in Italy died between 1995 and 2000.
   <sup>
    <xref rid="bibr41-0020731420946590" ref-type="bibr">41</xref>
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>Worldwide, 887,000 die yearly. Between 1993 and 2012, age-standardized, HBV-related liver mortality rates declined from 0.2 to 0.1 per 100 person-years (
   <italic>P</italic> &lt; .001).
   <sup>
    <xref rid="bibr42-0020731420946590" ref-type="bibr">42</xref>
   </sup>
  </p>
 </list-item>
 <list-item>
  <p>Incidence is higher in health care workers than in general population because of exposure to blood products.</p>
 </list-item>
 <list-item>
  <p>In Europe, 1.6% of the population is infected with HBV. In 2017, 30 European Union/European Economic Area member states reported 26,907 cases. The crude incidence rate was 6.7 cases per 100,000 population. R
   <sub>e</sub> is below 1 as the number of new cases continues to decline. In Europe, it causes 56,000 deaths per year.
   <sup>
    <xref rid="bibr43-0020731420946590" ref-type="bibr">43</xref>
   </sup>
  </p>
 </list-item>
</list>
